Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene
PaperCitations, authors & open-access status
European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 160 citations, 2014 year and closed oa status.
160
Citations
2014
Year
closed
OA Status